Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis
Ki-67 revealed differential proliferative activity in endometrial and myometrial cells across adenomyosis subtypes, with focal adenomyosis showing higher epithelial proliferation and stromal adenomyosis higher stromal cell proliferation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This immunocytochemical study assessed proliferative activity by detecting the Ki-67 antigen across endometrial and myometrial cell populations in focal versus stromal (diffuse) adenomyosis, comparing eutopic “normal” endometrium with ectopic glandular and stromal components. Ki-67 was present in multiple adenomyosis cell types, including endometrial and myometrial glandular epithelium, stromal cells, smooth muscle cells, and vascular endotheliocytes, with labeled indices differing by cell population. The highest labeled index occurred in endometrial gland epitheliocytes in focal adenomyosis (23.2±2.9%), while stromal adenomyosis showed about 2.8-fold lower values in gland epitheliocytes despite frequent association with glandular hyperplasia; secretory epitheliocytes had lower proliferative activity than normal eutopic endometrium. Relevance to endometriosis: Although the paper focuses on adenomyosis, it analyzes the proliferative behavior of ectopic endometrial-like cell populations within the myometrium, which is directly pertinent to endometriosis-related mechanisms of aberrant endometrial tissue proliferation.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,956 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-01T06:12:12.862213+00:00
- pubmed
- last seen: 2026-05-13T22:18:47.062786+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
Courtesy of the U.S. National Library of Medicine